Reactive angioendotheliomatosis as a side effect of long-acting injectable insulin use.

Stoll K, Holmes Seward S, Katona TM, Rahnama-Moghadam S

Open source

DOI
10.25251/d8bxg891
Published
2025 Sep 8
Container
Dermatology online journal
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.25251/d8bxg891,
  title = {Reactive angioendotheliomatosis as a side effect of long-acting injectable insulin use.},
  author = {Stoll K and Holmes Seward S and Katona TM and Rahnama-Moghadam S},
  year = {2025},
  journal = {Dermatology online journal},
  doi = {10.25251/d8bxg891},
  url = {https://doi.org/10.25251/d8bxg891}
}

RIS

TY  - JOUR
TI  - Reactive angioendotheliomatosis as a side effect of long-acting injectable insulin use.
AU  - Stoll K
AU  - Holmes Seward S
AU  - Katona TM
AU  - Rahnama-Moghadam S
PY  - 2025
JO  - Dermatology online journal
DO  - 10.25251/d8bxg891
UR  - https://doi.org/10.25251/d8bxg891
ER  - 

APA

K, S., S, H. S., TM, K., & S, R. (2025). Reactive angioendotheliomatosis as a side effect of long-acting injectable insulin use.. Dermatology online journal. https://doi.org/10.25251/d8bxg891

Source records